The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open-label, phase 2 study of emibetuzumab plus erlotinib (LY+E) and emibetuzumab monotherapy (LY) in patients with acquired resistance to erlotinib and MET diagnostic positive (MET Dx+) metastatic NSCLC.
 
D. Ross Camidge
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Teresa Moran
No Relationships to Disclose
 
Ingel Demedts
No Relationships to Disclose
 
Heidrun Grosch
No Relationships to Disclose
 
Jean-Pierre Di Mercurio
No Relationships to Disclose
 
Kathryn Finch Mileham
Honoraria - Boehringer Ingelheim; Covidien
Consulting or Advisory Role - Boehringer Ingelheim; Covidien; Novartis
Research Funding - Celgene
 
Julian R. Molina
No Relationships to Disclose
 
Oscar Juan Vidal
No Relationships to Disclose
 
Gerold Bepler
No Relationships to Disclose
 
Jonathan Wade Goldman
Honoraria - Clovis Oncology; Genentech
Research Funding - ArQule; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Synta
 
Conrad Lewanski
Honoraria - Celgene; Lilly; Roche
Consulting or Advisory Role - Celgene; Lilly; Roche
Travel, Accommodations, Expenses - Amgen; Lilly
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Hanmi; Kyowa Hakko Kirin; Lilly; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca
 
Johan Wallin
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Sameera R. Wijayawardana
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Xuejing Aimee Wang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Volker Wacheck
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Lilly
Travel, Accommodations, Expenses - Lilly (I)
 
Egbert F. Smit
No Relationships to Disclose